Digestives & Intestinal Remedies - Angola

  • Angola
  • In Angola, the revenue in the Digestives & Intestinal Remedies market market in 2024 amounts to US$21.52m.
  • It is projected to experience an annual growth rate of 3.34% (CAGR 2024-2029).
  • When compared globally, in China generates the highest revenue in this market, with US$4,408.00m in 2024.
  • In terms of per person revenues, US$0.57 is generated in 2024.
  • Despite the limited access to healthcare facilities, Angola has seen a growing demand for digestive and intestinal remedies in the OTC Pharmaceuticals market due to the prevalence of digestive disorders among its population.

Key regions: Brazil, India, United Kingdom, Germany, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestives & Intestinal Remedies market in Angola is experiencing steady growth due to increasing customer preferences for natural and herbal remedies, as well as the rising incidence of digestive disorders in the country.

Customer preferences:
Angolan consumers are increasingly seeking natural and herbal remedies for digestive issues, as they perceive them to be safer and more effective than conventional pharmaceutical products. This trend is driven by a growing awareness of the potential side effects of synthetic drugs and a desire for more holistic approaches to healthcare. As a result, there is a rising demand for digestive remedies that are made from natural ingredients, such as herbal teas, probiotics, and digestive enzymes.

Trends in the market:
The Digestives & Intestinal Remedies market in Angola is witnessing a shift towards preventive healthcare, with consumers proactively seeking products that promote digestive health and prevent digestive disorders. This trend is driven by a growing awareness of the importance of maintaining a healthy digestive system and the role it plays in overall well-being. As a result, there is an increasing demand for products that support gut health, such as prebiotics and dietary supplements.Furthermore, there is a rising demand for over-the-counter digestive remedies in Angola, as consumers are becoming more empowered to self-diagnose and self-treat minor digestive issues. This trend is driven by the increasing availability of information and resources online, which enable consumers to educate themselves about digestive disorders and find suitable remedies without consulting a healthcare professional.

Local special circumstances:
Angola has a rich tradition of using natural remedies for various health conditions, including digestive disorders. Traditional herbal medicine, known as "medicina tradicional," is widely practiced in the country, and many Angolan consumers prefer these remedies over conventional pharmaceutical products. This preference for traditional medicine is influenced by cultural beliefs and the perception that natural remedies are more aligned with the body's natural healing processes.

Underlying macroeconomic factors:
The Digestives & Intestinal Remedies market in Angola is also influenced by underlying macroeconomic factors. The country has experienced significant economic growth in recent years, leading to an increase in disposable income and a growing middle class. This has resulted in a higher purchasing power and an increased willingness to spend on healthcare products, including digestive remedies.Additionally, Angola has a young and rapidly growing population, which is driving the demand for healthcare products and services. The country's population is becoming more urbanized and adopting Western lifestyles, which often include unhealthy diets and sedentary lifestyles. This has led to a rise in digestive disorders, such as indigestion, bloating, and constipation, further fueling the demand for digestive remedies.In conclusion, the Digestives & Intestinal Remedies market in Angola is growing due to increasing customer preferences for natural and herbal remedies, a shift towards preventive healthcare, the rising demand for over-the-counter remedies, the preference for traditional medicine, and underlying macroeconomic factors such as economic growth and a growing population.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)